Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
Authors (first, second and last of 5)
Collection
Psychedelics and neural plasticity
BMC Neuroscience is welcoming submissions to a new article Collection focused on the study of psychedelics and their effects on neural plasticity in animal models and human patients. We hope to bring together new research that builds upon our understanding of this field and assists practitioners in devising novel treatment methods incorporating psychoactive substances.
Editors
-
Kacper Łukasiewicz
Dr Kacper Łukasiewicz received his BSc and MSc from the University of Warsaw and PhD from the Nencki Institute of Experimental Biology, Polish Academy of Sciences. In 2019 he joined Zou’s Laboratory at University of California Santa Cruz to conduct his postdoctoral research. In 2022 he moved back to Poland where he currently works at Psychiatry Clinic at Medical University of Bialystok as the Head of Laboratory. In his research he uses rodent models of neurologic and psychiatric disorders together with modern machine learning tools to understand underlying mechanisms.
-
Rachael Sumner
Rachael’s work focuses on mechanism-informed rational drug selection and human clinical trials. She has worked with LSD, ketamine, and scopolamine in the context of understanding novel treatments for depression and is excited by the potential for microdosing as well as macrodosing psychedelics in this space. She also has a particular passion for women’s health and menstrual cycle related disorders. Her work primarily involves using electroencephalography (EEG) with computational modelling, and blood analyte measurements to provide a mechanistic understanding of how drugs and disorder affect the brain.
